Marcus Autism Center EarliPoint Evaluation for early autism
Called the EarliPoint Evaluation, the tool has been authorized by the FDA for use with children between the ages of 16 and 30 months.
Stay updated with breaking news from Earlipoint Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Called the EarliPoint Evaluation, the tool has been authorized by the FDA for use with children between the ages of 16 and 30 months.
An innovative FDA-approved technology that measures children's eye movements while watching social interaction movies may speed up autism spectrum disorder diagnosis.
Autism is typically diagnosed in children when they are 4 or 5 years old, but a new tool could make earlier detection and intervention possible.
A revolutionary tool that monitors children's eye movements while they watch a video of a social interaction between two children could hasten the diagnosis of autism spectrum condition, according...
Two recent studies suggest that a newly developed eye-tracking tool may revolutionize the diagnosis of autism in young children. Currently, families often face long wait times for a diagnosis, and even then, the diagnosis may not be definitive. However, this tool, called EarliPoint Evaluation, has been cleared by the US Food and Drug Administration to assist clinicians in diagnosing and assessing autism.